Journal of Neuroimaging · 2003 · 52 citations · 21 references
MedicineNuclear MedicineOncologyChemotherapyMolecular ImagingNeuro-oncologyBrain TumorsCombination ChemotherapyNeuro-oncology ImagingPositron Emission TomographyTumor CharacterizationTumor ImagingAnticancer ChemotherapyChemotherapy Response AssessmentGlioblastoma ChemotherapyGlioma ChemotherapyOncologic Pet ImagingPositron Emission Tomography DetectionTumor Volume EstimationTumor Volume Measurement
The effect of chemotherapy with procarbazine, CCNU, and vincristine in an anaplastic oligoastrocytoma was monitored by repeated positron emission tomography (PET) with C-11-methionine (C-11-MET). Chemotherapy caused a continuous decline of active tumor volume at a rate of approximately 2.4% per day, resulting in complete remission that persisted until the end of follow-up at 3 years. Thus, the authors conclude that C-11-MET PET may be useful for monitoring chemotherapy in gliomas and deserves further study.
21
<sup>11</sup> C-methionine PET for differential diagnosis of low-grade gliomas
Karl Herholz, Thomas Hölzer, Bernd Bauer et al. · Neurology · 1998 · 397 citations
Medicine, Nuclear Medicine, Oncology +14
Leif Østergaard, Fred H. Hochberg, James D. Rabinov et al. · Journal of neurosurgery · 1999 · 171 citations